BX Swiss TOP 30 CHF

BX Swiss TOP 30 CHF handeln
1.500,06 PKT +23,66 PKT +1,60 %
finanzen.net zero
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Smartphone

WKN SL0CLV

ISIN DE000SL0CLV3


Analysen zu BX Swiss TOP 30 CHF-Werten

Datum Rating Analyst
30.11.12 UBS outperform Exane-BNP Paribas SA
30.11.12 Roche buy Sarasin Research
30.11.12 Holcim hold Société Générale Group S.A. (SG)
30.11.12 Holcim overweight Morgan Stanley
30.11.12 Holcim equal-weight Morgan Stanley
30.11.12 Novartis outperform Sanford C. Bernstein and Co., Inc.
30.11.12 Zurich Insurance hold Vontobel Research
30.11.12 Zurich Insurance outperform Sanford C. Bernstein and Co., Inc.
30.11.12 Roche outperform Sanford C. Bernstein and Co., Inc.
29.11.12 Swiss Life neutral J.P. Morgan Cazenove
29.11.12 Zurich Insurance neutral Sarasin Research
29.11.12 Swiss Life buy Nomura
29.11.12 Richemont buy Sarasin Research
29.11.12 Swiss Life buy Vontobel Research
29.11.12 Lonza hold Vontobel Research
29.11.12 Zurich Insurance hold Vontobel Research
28.11.12 UBS outperform Credit Suisse Group
28.11.12 Swiss Re neutral Exane-BNP Paribas SA
28.11.12 UBS overweight J.P. Morgan Cazenove
28.11.12 Adecco SA buy Vontobel Research
28.11.12 Swiss Life buy Vontobel Research
28.11.12 Swiss Life buy Sarasin Research
27.11.12 Nestlé kaufen Hamburger Sparkasse AG (Haspa)
27.11.12 Novartis kaufen Hamburger Sparkasse AG (Haspa)
26.11.12 Straumann hold Vontobel Research
26.11.12 Lonza hold Vontobel Research
26.11.12 Swiss Re neutral Sarasin Research
26.11.12 UBS neutral Macquarie Research
26.11.12 Swiss Re buy Vontobel Research
26.11.12 Straumann neutral Sarasin Research
26.11.12 Richemont buy Sarasin Research
23.11.12 Sonova kaufen Fuchsbriefe
23.11.12 ABB (Asea Brown Boveri) outperform Sanford C. Bernstein and Co., Inc.
22.11.12 Zurich Insurance neutral Credit Suisse Group
22.11.12 Zurich Insurance neutral J.P. Morgan Cazenove
22.11.12 Holcim buy UBS AG
22.11.12 Holcim buy UBS AG
22.11.12 Swiss Life buy UBS AG
22.11.12 Holcim hold Vontobel Research
21.11.12 UBS overweight Morgan Stanley